Depemokimab for treating severe eosinophilic asthma in people 12 years and over ID6447Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Digital platforms to support self-management of asthma : early value assessmentStatus:Awaiting developmentProgramme:Health technology evaluationExpected publication date: TBC